Alterity Therapeutics Ltd (ATHE) — Long-term Investment Intensity

Latest as of June 2016: 0.1%

Alterity Therapeutics Ltd (ATHE) has a Long-term Investment Intensity of 0.1% as of June 2016. Long-term investments of $43.99K represent 0.1% of total assets of $33.73 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check total reinvestment intensity of Alterity Therapeutics Ltd to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.1%
LT Investments / Total Assets

Long-term Investments

$43.99K
USD

Total Assets

$33.73 Million
USD

Country

USA
NASDAQ

Alterity Therapeutics Ltd Long-term Investment Intensity (2016–2016)

This chart shows how Alterity Therapeutics Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2016 to 2016. As of June 2016, the intensity stands at 0.1%, reflecting long-term investments of $43.99K against total assets of $33.73 Million USD. Explore cash flow to debt ratio of Alterity Therapeutics Ltd to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Alterity Therapeutics Ltd (2016–2016)

The table below presents the year-by-year Long-term Investment Intensity for Alterity Therapeutics Ltd from 2016 to 2016, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ATHE stock market capitalisation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2016 0.1% $43.99K $33.73 Million
pp = percentage points